Both promoters are considered to be the major promoters driving aromatase expression in breast cancer and surrounding adipose tissue, accounting for 80–90% of total aromatase expression (Bulun et al, 2005; Chen et al, 2009). Here, CYP19A1 is linked to breast cancer.